Neurodiagnostics Market Size to Attain $14.91 Billion by 2031: Coherent Market Insights
June 20, 2024 04:25 ET
|
CMI
Burlingame, June 20, 2024 (GLOBE NEWSWIRE) -- The dynamic landscape of global neurodiagnostics market share, is projected to reach USD 14.94 billion in revenue by 2031. growing at a CAGR of 8.1% by...
Global Neurological Diagnostic and Monitoring Equipment Market Predicted to Reach $17.33 Billion by 2028
October 16, 2023 05:43 ET
|
Research and Markets
Dublin, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The "Neurological Diagnostic and Monitoring Equipment - Global Market Insights, Competitive Landscape, and Market Forecast - 2028" report has been added to ...
Strategic Report on Neurodiagnostics Market: Key Segments, Trends, and Future Prospects 2022 to 2030
August 08, 2023 08:43 ET
|
Research and Markets
Dublin, Aug. 08, 2023 (GLOBE NEWSWIRE) -- The "Neurodiagnostics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The "Neurodiagnostics - Global...
Neurodiagnostics Market accounted for US$ 7.22 billion in 2022 and is estimated to be US$ 17.8 billion by 2032 and is anticipated to register a CAGR of 11.8% - By PMI
December 12, 2022 09:02 ET
|
PMI
Covina, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Neurodiagnostics is the study of brain in which it records activity of brain & central nervous system to evaluate if it functions correctly. Various...
Worldwide Neurodiagnostics Industry to 2025 - Increasing Application in Clinical Trials Presents Opportunities
March 04, 2021 07:23 ET
|
Research and Markets
Dublin, March 04, 2021 (GLOBE NEWSWIRE) -- The "Global Neurodiagnostics market (2020-2025) by Product Type, Condition, End user, Geography and the Impact of Covid-19 with Ansoff Analysis" report has...
Global Alzheimer Diagnostic Testing Devices Pipeline Report 2020 - Stage of Development, Territory, Regulatory Path, Estimated Approval Date, Ongoing Clinical Trials
December 23, 2020 07:28 ET
|
Research and Markets
Dublin, Dec. 23, 2020 (GLOBE NEWSWIRE) -- The "Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering. "Alzheimer...
Neurodiagnostics Market To Reach USD 25.14 Billion By 2026 | Reports And Data
November 26, 2019 10:24 ET
|
Reports and Data
New york, Nov. 26, 2019 (GLOBE NEWSWIRE) -- High prevalence of neurological disorders, adoption of novel diagnostic technology, product launches, increasing strategic developments such as...
Neurodiagnostics Market To Reach USD 25.14 Billion By 2026 | Reports And Data
November 26, 2019 10:24 ET
|
Reports and Data
New york, Nov. 26, 2019 (GLOBE NEWSWIRE) -- High prevalence of neurological disorders, adoption of novel diagnostic technology, product launches, increasing strategic developments such as...
Neuronetrix publishes peer-reviewed paper validating the clinical application of ERP biomarkers for use in Alzheimer's disease
November 18, 2015 10:22 ET
|
Neuronetrix
LOUISVILLE, Ky., Nov. 18, 2015 (GLOBE NEWSWIRE) -- Neuronetrix announced today the publication of results from its multi-center clinical trial in a prestigious Alzheimer's journal. The report, "A...
Neuronetrix joins big pharma to sponsor conference on Clinical Trials for Alzheimer's Disease
October 29, 2015 14:03 ET
|
Neuronetrix
LOUISVILLE, Ky., Oct. 29, 2015 (GLOBE NEWSWIRE) -- Neuronetrix announced today that it has joined pharma giants Lilly, Roche, Lundbeck, Janssen, and others to sponsor the 8th Annual Clinical Trials on...